Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751907 · ClinicalTrials.gov registry record · Phase 2
Cerebral and Peripheral Perfusion Pilot Study
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00751907 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants.
The verdict
NCT00751907, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the hypothesis that in middle-aged, asymptomatic, adult children of persons with Alzheimer's disease (AD), atorvastatin therapy will beneficially affect mechanisms thought to contribute to AD risk by improving blood flow in the brain, improving cerebral perfusion, increasing brain activity patterns, and improving blood vessel function.
Interventions
- DRUG Placebo
- DRUG atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00751907
The ClinicalTrials.gov registry entry for NCT00751907 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00751907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00751907 about?
NCT00751907 is a clinical study titled "Cerebral and Peripheral Perfusion Pilot Study". The purpose of this study is to evaluate the hypothesis that in middle-aged, asymptomatic, adult children of persons with Alzheimer's disease (AD), atorvastatin therapy will beneficially affect mechanisms thought to contribute to AD risk by improving blood flow in the brain, improving cerebral perfu...
What is the current status of trial NCT00751907?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2006-06. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00751907?
The interventions under investigation include: Placebo (DRUG), atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00751907?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.